EdgeBio has received CLIA certification for its next-generation sequencing operations and has launched a clinical exome test.
The company has been offering next-gen sequencing services and sequencing products since 2008, and currently offers sequencing services on Illumina's HiSeq, Life Technologies' SOLiD 4, and the Ion Torrent PGM.
"For the past three years we have been building expertise in both the generation and analysis of data via NGS in a research setting," CEO Dean Gaalaas said in a statement. "Receiving CLIA certification now allows us to leverage this expertise to help clinicians better diagnose and treat their patients."
EdgeBio joins a number of commercial and academic laboratories offering clinical exome tests, including Ambry Genetics; the University of California, Los Angeles; Washington University's School of Medicine; and Emory University (CSN 3/7/2012, CSN 2/29/2012, CSN 3/21/2012).